Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,deferredLongTermLiab,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,inventory,accountsPayable,shortLongTermDebt,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,trailingPE,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,marketState,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,exchange,priceHint,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry
t0,ELXMF,33635000.0,143600992,,,-802500,,-802500,3001500,2637000,-973500,-973500,232000,-18500,,,,0,3690000,4663500,1053000,171000,,-802500,-802500,3456000.0,14531000.0,37091000.0,7795000.0,8170000.0,51622000.0,36678000.0,3643000.0,365000.0,-3230000.0,7838000.0,29476000.0,12687000.0,-3230000.0,3040000.0,37288000.0,4363000.0,3239000.0,2688000.0,,0,-881000,-72500,-30587500,-33086500,-20822000,-36500,-1581500,377000,77500,-9693000,-1156000,-83000,24601000.0,en-US,US,EQUITY,False,Delayed Quote,0.0,0.26 - 0.26,0.26,0.0,0.0,0,0,finmb_1898661,Other OTC,Nova Eye Medical Limited,AUD,216,0,0.07999998,0.44444433,0.18 - 0.475,-0.215,-0.4526316,0.18,0.475,1.3471502,-14400000,False,False,USD,REGULAR,0.193,0.259,0.2881818,-0.028181821,-0.09779181,0.248,0.0119999945,0.048387077,41156960,1.003861,15,America/New_York,EDT,NOVA EYE MEDICAL LIMITED,0.26,1628605716,0.0,0.26,0.26,0.26,5700,0,PNK,4,us_market,0.59,,,0.475,0.18,0.2882,0.248,216,,143.6M,,118.78M,20.62%,25.51%,,,,,,,,,,,,,,,,"Jun 29, 2020","Dec 30, 2020",288.68%,-43.32%,-4.60%,-17.46%,12.72M,0.09,-0.60%,9.75M,-4.04M,-9M,0.1930,,29.48M,0.21,3.31M,8.92,2.94,0.26,410k,46.61M,Value,5067,,"Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.",Kent Town,SA,1609372800,Australia,http://www.nova-eye.com,86400,107 Rundle Street,
t-1,ELXMF,33635000.0,143600992,,,-802500,,-802500,3001500,2637000,-973500,-973500,232000,-18500,,,,0,3690000,4663500,1053000,171000,,-802500,-802500,3456000.0,14531000.0,37091000.0,7795000.0,8170000.0,51622000.0,36678000.0,3643000.0,365000.0,-3230000.0,7838000.0,29476000.0,12687000.0,-3230000.0,3040000.0,37288000.0,4363000.0,3239000.0,2688000.0,,0,-881000,-72500,-30587500,-33086500,-20822000,-36500,-1581500,377000,77500,-9693000,-1156000,-83000,24601000.0,en-US,US,EQUITY,False,Delayed Quote,0.0,0.26 - 0.26,0.26,0.0,0.0,0,0,finmb_1898661,Other OTC,Nova Eye Medical Limited,AUD,216,0,0.07999998,0.44444433,0.18 - 0.475,-0.215,-0.4526316,0.18,0.475,1.3471502,-14400000,False,False,USD,REGULAR,0.193,0.259,0.2881818,-0.028181821,-0.09779181,0.248,0.0119999945,0.048387077,41156960,1.003861,15,America/New_York,EDT,NOVA EYE MEDICAL LIMITED,0.26,1628605716,0.0,0.26,0.26,0.26,5700,0,PNK,4,us_market,0.59,,,0.475,0.18,0.2882,0.248,216,,143.6M,,118.78M,20.62%,25.51%,,,,,,,,,,,,,,,,"Jun 29, 2020","Dec 30, 2020",288.68%,-43.32%,-4.60%,-17.46%,12.72M,0.09,-0.60%,9.75M,-4.04M,-9M,0.1930,,29.48M,0.21,3.31M,8.92,2.94,0.26,410k,46.61M,Value,5067,,"Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.",Kent Town,SA,1609372800,Australia,http://www.nova-eye.com,86400,107 Rundle Street,
t-2,ELXMF,97245000.0,143600992,,,-802500,,0,3001500,0,0,-973500,232000,-18500,,,,0,0,0,0,0,,-802500,-802500,3341000.0,16156000.0,100586000.0,7536000.0,8159000.0,116742000.0,78311000.0,24634000.0,365000.0,-2359000.0,7584000.0,95649000.0,14358000.0,-2359000.0,2912000.0,102905000.0,3828000.0,2934000.0,3826000.0,1554000.0,0,-881000,-72500,-30587500,-33086500,-20822000,-36500,-1581500,377000,77500,-9693000,-1156000,-83000,88547000.0,en-US,US,EQUITY,False,Delayed Quote,0.0,0.26 - 0.26,0.26,0.0,0.0,0,0,finmb_1898661,Other OTC,Nova Eye Medical Limited,AUD,216,0,0.07999998,0.44444433,0.18 - 0.475,-0.215,-0.4526316,0.18,0.475,1.3471502,-14400000,False,False,USD,REGULAR,0.193,0.259,0.2881818,-0.028181821,-0.09779181,0.248,0.0119999945,0.048387077,41156960,1.003861,15,America/New_York,EDT,NOVA EYE MEDICAL LIMITED,0.26,1628605716,0.0,0.26,0.26,0.26,5700,0,PNK,4,us_market,0.59,,,0.475,0.18,0.2882,0.248,216,,143.6M,,118.78M,20.62%,25.51%,,,,,,,,,,,,,,,,"Jun 29, 2020","Dec 30, 2020",288.68%,-43.32%,-4.60%,-17.46%,12.72M,0.09,-0.60%,9.75M,-4.04M,-9M,0.1930,,29.48M,0.21,3.31M,8.92,2.94,0.26,410k,46.61M,Value,5067,,"Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.",Kent Town,SA,1609372800,Australia,http://www.nova-eye.com,86400,107 Rundle Street,
t-3,ELXMF,97245000.0,143600992,,,-802500,,0,3001500,0,0,-973500,232000,-18500,,,,0,0,0,0,0,,-802500,-802500,3341000.0,16156000.0,100586000.0,7536000.0,8159000.0,116742000.0,78311000.0,24634000.0,365000.0,-2359000.0,7584000.0,95649000.0,14358000.0,-2359000.0,2912000.0,102905000.0,3828000.0,2934000.0,3826000.0,1554000.0,0,-881000,-72500,-30587500,-33086500,-20822000,-36500,-1581500,377000,77500,-9693000,-1156000,-83000,88547000.0,en-US,US,EQUITY,False,Delayed Quote,0.0,0.26 - 0.26,0.26,0.0,0.0,0,0,finmb_1898661,Other OTC,Nova Eye Medical Limited,AUD,216,0,0.07999998,0.44444433,0.18 - 0.475,-0.215,-0.4526316,0.18,0.475,1.3471502,-14400000,False,False,USD,REGULAR,0.193,0.259,0.2881818,-0.028181821,-0.09779181,0.248,0.0119999945,0.048387077,41156960,1.003861,15,America/New_York,EDT,NOVA EYE MEDICAL LIMITED,0.26,1628605716,0.0,0.26,0.26,0.26,5700,0,PNK,4,us_market,0.59,,,0.475,0.18,0.2882,0.248,216,,143.6M,,118.78M,20.62%,25.51%,,,,,,,,,,,,,,,,"Jun 29, 2020","Dec 30, 2020",288.68%,-43.32%,-4.60%,-17.46%,12.72M,0.09,-0.60%,9.75M,-4.04M,-9M,0.1930,,29.48M,0.21,3.31M,8.92,2.94,0.26,410k,46.61M,Value,5067,,"Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.",Kent Town,SA,1609372800,Australia,http://www.nova-eye.com,86400,107 Rundle Street,
